[Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis].
The AA. have studied the Desferrioxamine ototoxicity with high frequency audiometry (HFA), given the drug as a test for diagnosis of aluminium-related done disease in patients under dialysis. The dose of 10 mg/kg presents high sensitivity and low ototoxicity.